1996
National Household Survey on Drug Abuse: Preliminary Results
70617 (78B) PRELIMINARY DATA - AS OF JUNE 1997
Table 38B.Percentages Reporting Lifetime Use of Specific Hallucinogens,
Inhalants, Methamphetamine, Needles, and Heroin by Smoking or Sniffing/Snorting
It in the U.S. Population Aged 12 and Older, by Age Group: 1995 and 1996
Drug or Method of Administration
AGE GROUP (Years)
12-17
18-25
26-34
35 and Older
Total
1995
1996
1995
1996
1995
1996
1995
1996
1995
1996
Hallucinogens
5.4
5.6
14.1a
16.3
15.2
15.4
7.6
7.3
9.5
9.7
PCP
1.6
1.2
3.0
2.3
4.6
4.2
3.1
3.4
3.2
3.2
LSD
4.3
4.3
12.0a
13.9
11.7
11.7
5.8
5.8
7.5
7.7
Peyote
0.5
0.4
1.0
1.5
2.0a
1.3
2.5
2.4
2.0
1.9
Mescaline
0.4
0.3
1.8
2.2
3.6
3.1
3.9
3.4
3.2
2.8
Psilocybin (Mushrooms)
1.7
2.0
6.7b
9.1
8.3
8.6
4.2
4.2
4.9
5.3
"Ecstasy" (MDMA)
1.2
1.1
3.5
4.2
2.8
2.5
1.0
0.7
1.6
1.5
Inhalants
7.4
5.9
11.2
10.8
8.7
8.3
3.3
3.6
5.7
5.6
Amyl Nitrite, "Poppers," Locker Room Odorizers, or "Rush"
0.6
0.6
3.0
2.3
5.2
4.7
2.1
2.3
2.6
2.5
Correction Fluid, Degreaser, or Cleaning Fluid
1.6
1.8
1.7
1.0
0.4
0.5
0.4
0.1
0.7
0.5
Gasoline or Lighter
Fluid
3.1b
1.9
2.4
2.4
1.4
0.9
0.3
0.2
1.1a
0.8
Glue, Shoe Polish, or Toluene
2.9
2.2
2.5
1.8
1.6
1.1
0.6
0.5
1.3b
0.9
Halothane, Ether, or Other Anesthetics
0.4
0.2
0.5
0.4
0.3
0.3
0.3
0.1
0.3
0.2
Lacquer Thinner or Other Paint Solvents
1.8
1.4
0.9
1.1
0.5
0.4
0.1
0.1
0.5
0.4
Lighter Gases (Butane, Propane)
1.5a
0.9
1.0
1.0
0.3
0.3
0.0
0.0
0.3
0.3
Nitrous Oxide or "Whippets"
1.4
1.8
6.2
7.2
3.2
4.0
1.2
1.0
2.2
2.4
Spray Paints
2.1
1.4
0.9
1.0
0.5
0.7
0.2
0.2
0.5
0.5
Other Aerosol Sprays
1.5
1.4
1.1
1.0
0.3
0.5
0.2
0.1
0.5
0.4
Methamphetamine
0.8
0.6
1.9a
2.5
3.8
4.2
2.1
2.0
2.2
2.3
Needle Use1,2
0.4
0.3
0.7
1.0
2.1
1.7
1.4
1.2
1.3
1.2
Heroin
0.7
0.5
0.7
1.3
1.5
1.3
1.2
1.2
1.2
1.1
Smoke Heroin2
0.5
0.4
0.5
0.6
0.7
0.8
0.7
0.9
0.7
0.8
Sniff or Snort Heroin2
0.3
0.2
0.5
0.8
0.9
0.9
0.7
1.0
0.6
0.9
*Low precision; no estimate reported.
1 Refers to lifetime use of a needle to inject a drug that
was not prescribed, or that was taken only for the experience or feeling
it caused.
2 These drug estimates are generated from data collected
on a "non-core" section of the NHSDA questionnaire. Therefore,
these estimates may be somewhat inconsistent with drug estimates based
on data
collected from the "core" answer sheets because NHSDA data
are not edited for consistency across the "core" and" non-core"
sections of the interview.
aDifference between 1995 and 1996 is statistically significant
at the .05 level.
bDifference between 1995 and 1996 is statistically significant
at the .01 level.
Source: SAMHSA, Office of Applied Studies, National Household Survey
on Drug Abuse, 1995 and 1996.
